Current plan
Explorer
Upgrade
payment warning Payment details required
limit warning One or more limits reached
Daily profile views
0 / 3
Monthly profile views
0 / 15
Searches (last 30 days)
0 / 10
No linked companies
Get featured as a Team Member in a Finder company.
Team Member at
Add Entity
snc-logo

Startup Nation Finder

My Watchlists
Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
BI Dashboards toggle bi dashboards submenu
Saved Searches
Following
Messaging
Notifications
About Us
Glossary
Current plan
Explorer
Pricing plans
warning Payment details required
Daily profile views
0 / 3
Monthly profile views
0 / 15
Searches (last 30 days)
0 / 10

Your CSV is on the way

We’ve sent your CSV file to
send file

Upgrade your Finder plan

  • ✓Basic CSV download
  • ✓Unlimited profile visits
  • ✓Unlimited searches
  • ✓Ecosystem reports
  • ✓Saved searches, Watchlists & notifications

Provide your business email

To complete this action, please provide your Business email.

Verify your business email

You only need to verify it once.
We’ve sent a verification link to

Create Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
0/300
Notifications Settings
Public content (accessible by all Finder users)

Add to List

    Notifications settings

    Set Notifications
    Off
    Select notifications to recieve tooltip-info
    Select all

    Email Alerts

    Receive notifications via email

    No Notifications are selected

    Would you like to select any notifications?
    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Create Free Account
    Lock Icon
    Lock Icon
    8 Characters, Uppercase letter (A-Z),
    Lowercase letter (a-z), Digit (0-9)
    Lock Icon
    Passwords do not match
    Already have an account? Sign In
    Or continue with

    Verify your email

    We’ve sent a verification link to email@email.com
    Sign in
    Lock Icon
    Lock Icon
    Reset password
    Don't have an account? Create Account
    Or continue with

    Check your mailbox

    We sent you an email with further instructions to
    email@email.com

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Dynamic List | Current Companies undefined
    Auto-updated as companies match your search. Ideal for tracking a market of interest
    Search Description
    undefined
    Search must have a valid name.
    Receive notifications via email

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    disclaimer-icon
    Summary generated by AI
    Read article
    snackbar-icon
    title
    message
    Home > Multinationals > AstraZeneca
    Claimed by owner • Last Update Apr 27, 2026 • Suggest Edits • Claim Profile
    Claimed by owner
    AstraZeneca

    AstraZeneca

    Pharmaceuticals • United Kingdom

    PUBLIC on LSE on Jun, 1993
    PUBLIC on NYSE on Jun, 1993
    Terms of Use
    AstraZeneca
    About
    Affiliations
    Israeli Portfolio
    News
    Gallery
    May 18, 2026
    www.marketbeat.com
    Compugen Q1 Earnings Call Highlights
    May 7, 2026
    www.calcalistech.com
    Biotech company’s immune-system modeling platform will continue supporting oncology drug development through 2027.
    Apr 26, 2026
    finance.yahoo.com
    AstraZeneca PLC (AZN): One of the Best Low Risk High Growth Firms
    Apr 14, 2026
    finance.yahoo.com
    J&J Beats Q1 Earnings & Sales Estimates, Raises 2026 Outlook
    Apr 13, 2026
    www.marketbeat.com
    Compugen Highlights AI-Driven IO Pipeline, Key Trial Timelines and Big Pharma Partnerships at Needham Conference
    Apr 2, 2026
    247wallst.com
    Here Are Thursday’s Top Wall Street Analyst Research Calls: Akamai Technologies, Astra-Zeneca, Brinker, e.l.f. Beauty, Freeport-McMoran, Vale, Wingstop, Wix.com, and More
    Mar 12, 2026
    finance.yahoo.com
    Compugen Ltd. (CGEN) Reports Q4 Revenue of $67.3 Million vs. $1.5 Million Last Year
    Mar 4, 2026
    finance.yahoo.com
    Compugen Ltd (CGEN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
    #Product Stage #Partners #Investment
    Mar 3, 2026
    finance.yahoo.com
    7MM Asthma Market Insights, Epidemiology, and Market Forecast Report 2022-2036
    #Product Stage #FDA approved/pending approval
    Mar 2, 2026
    finance.yahoo.com
    Compugen Reports Fourth Quarter and Full Year 2025 Results
    #Product Stage #Partners #Management Changes
    Mar 2, 2026
    app.moby.co
    Compugen Ltd. Q4 2025 Earnings Call Summary
    Feb 7, 2026
    finance.yahoo.com
    Super Bowl LX, Coinbase earnings, jobs data & CPI: What to Watch
    Jan 14, 2026
    finance.yahoo.com
    Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday Ahead of Expected Supreme Court Decision on Tariffs
    Dec 17, 2025
    finance.yahoo.com
    Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million
    #Partners #Investment
    Dec 17, 2025
    www.prnewswire.com
    /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target...
    #Partners #Investment
    Dec 17, 2025
    en.globes.co.il
    Under new CEO Eran Ophir, the Israeli drug discovery and development company has converted potential future royalties into immediate cash.
    #Product Stage #Investment #Management Changes #Partners
    Nov 26, 2025
    finance.yahoo.com
    Medicare Slashes Ozempic's Price Tag 71%; Why Novo Nordisk Rallied
    Nov 5, 2025
    finance.yahoo.com
    Earnings live: AMD, Supermicro, and Novo Nordisk stocks fall, Pinterest tanks while Lemonade gets a boost
    Oct 20, 2025
    finance.yahoo.com
    3 UK Stocks That May Be Undervalued In October 2025
    #Management Changes
    Oct 8, 2025
    finance.yahoo.com
    AstraZeneca's Baxdrostat Meets Goal in Resistant Hypertension Study
    #Product Stage
    Jul 3, 2025
    finance.yahoo.com
    Sector Update: Health Care Stocks Mixed Thursday Afternoon
    Jul 1, 2025
    finance.yahoo.com
    Sector Update: Health Care Stocks Rise in Late Afternoon Trading
    Jun 24, 2025
    www.thedailyupside.com
    Markets Stay Relatively Calm as Fragile Ceasefire Deal Follows Missile Strikes
    Jun 13, 2025
    www.biopharmadive.com
    AstraZeneca forms an AI deal in China; Third Harmonic advances liquidation plans
    #Partners #Investment
    Apr 28, 2025
    en.globes.co.il
    The UK pharmaceutical giant is teaming with Tel Aviv University and the Meuhedet and Leumit health funds on the project.
    #Partners
    Sep 26, 2024
    www.timesofisrael.com
    Israeli AI startup forges $18m partnership with AstraZeneca for cancer drug trials
    Feb 8, 2024
    www.wsj.com
    AstraZeneca Shares Drop on Weak Quarterly Report Despite 2024 Growth Guidance
    Jan 21, 2024
    www.jpost.com
    Israel’s Immunai could be the secret weapon to faster drug approvals American-Israeli company announces latest success story with AstraZeneca.
    #Partners
    Apr 3, 2022
    www.calcalistech.com
    AstraZeneca innovation hub seeking Israeli tech as it broadens search for innovation CTech
    #Partners #Investment
    Oct 19, 2021
    www.jpost.com
    https://www.jpost.com/health-and-wellness/pfizer-astrazeneca-help-launch-computational-science-lab-in-israel-682248
    #Partners #Investment #Expand
    Feb 24, 2020
    www.jvpvc.com
    JVP and AstraZeneca Launch Joint Digital-Health Initiative - JVP
    #Partners #Investment

    About

    AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

    AstraZeneca Israel was established at the end of 2008 and is based in Kfar Saba, employing over 100 people, specializing in sales, marketing, medical & regulatory affairs. In addition, AstraZeneca Israel has a strong presence of scientific research and development with partnerships across the country.

    In May 2019 AstraZeneca signed a MOU (memorandum of understanding) with the Israeli innovation authority, committing to invest and support the Israeli healthcare ecosystem. AstraZeneca Israel is proud to be an active part of the AstraZeneca Health Innovation Hubs network alongside the US, China, Sweden, and France

    Founded

    In Israel Since

    Employees Worldwide

    Employees In Israel

    Market Cap

    Market Cap Update

    1/2026

    Country

    United Kingdom

    News

      (31)
    May 18, 2026
    www.marketbeat.com
    Compugen Q1 Earnings Call Highlights
    May 7, 2026
    www.calcalistech.com
    Biotech company’s immune-system modeling platform will continue supporting oncology drug development through 2027.
    Apr 26, 2026
    finance.yahoo.com
    AstraZeneca PLC (AZN): One of the Best Low Risk High Growth Firms
    Apr 14, 2026
    finance.yahoo.com
    J&J Beats Q1 Earnings & Sales Estimates, Raises 2026 Outlook
    Apr 13, 2026
    www.marketbeat.com
    Compugen Highlights AI-Driven IO Pipeline, Key Trial Timelines and Big Pharma Partnerships at Needham Conference
    Apr 2, 2026
    247wallst.com
    Here Are Thursday’s Top Wall Street Analyst Research Calls: Akamai Technologies, Astra-Zeneca, Brinker, e.l.f. Beauty, Freeport-McMoran, Vale, Wingstop, Wix.com, and More
    Mar 12, 2026
    finance.yahoo.com
    Compugen Ltd. (CGEN) Reports Q4 Revenue of $67.3 Million vs. $1.5 Million Last Year
    Mar 4, 2026
    finance.yahoo.com
    Compugen Ltd (CGEN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
    #Product Stage #Partners #Investment
    Mar 3, 2026
    finance.yahoo.com
    7MM Asthma Market Insights, Epidemiology, and Market Forecast Report 2022-2036
    #Product Stage #FDA approved/pending approval
    Mar 2, 2026
    finance.yahoo.com
    Compugen Reports Fourth Quarter and Full Year 2025 Results
    #Product Stage #Partners #Management Changes
    Mar 2, 2026
    app.moby.co
    Compugen Ltd. Q4 2025 Earnings Call Summary
    Feb 7, 2026
    finance.yahoo.com
    Super Bowl LX, Coinbase earnings, jobs data & CPI: What to Watch
    Jan 14, 2026
    finance.yahoo.com
    Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday Ahead of Expected Supreme Court Decision on Tariffs
    Dec 17, 2025
    finance.yahoo.com
    Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million
    #Partners #Investment
    Dec 17, 2025
    www.prnewswire.com
    /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target...
    #Partners #Investment
    Dec 17, 2025
    en.globes.co.il
    Under new CEO Eran Ophir, the Israeli drug discovery and development company has converted potential future royalties into immediate cash.
    #Product Stage #Investment #Management Changes #Partners
    Nov 26, 2025
    finance.yahoo.com
    Medicare Slashes Ozempic's Price Tag 71%; Why Novo Nordisk Rallied
    Nov 5, 2025
    finance.yahoo.com
    Earnings live: AMD, Supermicro, and Novo Nordisk stocks fall, Pinterest tanks while Lemonade gets a boost
    Oct 20, 2025
    finance.yahoo.com
    3 UK Stocks That May Be Undervalued In October 2025
    #Management Changes
    Oct 8, 2025
    finance.yahoo.com
    AstraZeneca's Baxdrostat Meets Goal in Resistant Hypertension Study
    #Product Stage
    Jul 3, 2025
    finance.yahoo.com
    Sector Update: Health Care Stocks Mixed Thursday Afternoon
    Jul 1, 2025
    finance.yahoo.com
    Sector Update: Health Care Stocks Rise in Late Afternoon Trading
    Jun 24, 2025
    www.thedailyupside.com
    Markets Stay Relatively Calm as Fragile Ceasefire Deal Follows Missile Strikes
    Jun 13, 2025
    www.biopharmadive.com
    AstraZeneca forms an AI deal in China; Third Harmonic advances liquidation plans
    #Partners #Investment
    Apr 28, 2025
    en.globes.co.il
    The UK pharmaceutical giant is teaming with Tel Aviv University and the Meuhedet and Leumit health funds on the project.
    #Partners
    Sep 26, 2024
    www.timesofisrael.com
    Israeli AI startup forges $18m partnership with AstraZeneca for cancer drug trials
    Feb 8, 2024
    www.wsj.com
    AstraZeneca Shares Drop on Weak Quarterly Report Despite 2024 Growth Guidance
    Jan 21, 2024
    www.jpost.com
    Israel’s Immunai could be the secret weapon to faster drug approvals American-Israeli company announces latest success story with AstraZeneca.
    #Partners
    Apr 3, 2022
    www.calcalistech.com
    AstraZeneca innovation hub seeking Israeli tech as it broadens search for innovation CTech
    #Partners #Investment
    Oct 19, 2021
    www.jpost.com
    https://www.jpost.com/health-and-wellness/pfizer-astrazeneca-help-launch-computational-science-lab-in-israel-682248
    #Partners #Investment #Expand
    Feb 24, 2020
    www.jvpvc.com
    JVP and AstraZeneca Launch Joint Digital-Health Initiative - JVP
    #Partners #Investment

    The Team

    (3)
    OG
    Ohad Goldberg
    President
    L
    Liron Abaranok Noy
    Innovation & Business Excellence Director
    SE
    Shaon Ein-Gal
    External AI Innovation Lead

    Connect with

    What is the reason for connecting? *
    Please select a reason
    Your company *
    Please fill out this field

    Your organization type *

    Please fill out this field
    Please select a type
    Your position *
    Please fill out this field
    Add invitation message
    0/300

    Sending invitation...

    Israeli Portfolio

    (2)
    Company Name Description Founded Business Model Employees Funding Stage Raised
    DenovAI Biotech logo
    DenovAI Biotech
    Dynamic Protein Design 2023 B2B 11-50 Seed $4M
    ProPhet logo
    ProPhet
    AI-driven Drug Discovery 2024 B2B 1-10 Pre-Seed $1M

    Locations

    Israel

    Atir Yeda Street 1, Kefar Sava, Israel

    Offices Abroad

    Cambridge, UK

    Locations

    Israel

    Atir Yeda Street 1, Kefar Sava, Israel

    Offices Abroad

    Cambridge, UK

    Notes

    Content Writer
    undefined
    BI Verification
    undefined
    Phone Number
    undefined
    Israel Register ID
    undefined
    Confidence Score
    undefined
    Missing Fields
    undefined
    Profile Creator
    undefined
    Profile Update
    undefined
    undefined

    Add Article

    0/500